Related Experiment Video
Updated: May 23, 2025
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Development and psychometric validation of a patient-reported outcome measure scale for Crohn's disease anorectal
Jin-Rong Li1,2, Bo-Lin Yang1,2, Zhen-Xing Zhu1,2
1Department of Colorectal Surgery, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Background:
Anorectal stricture is a severe and debilitating complication of Crohn's disease (CD). Currently, no specific patient-reported outcome measures (PROMs) exist to assess the severity of anorectal stricture or its impact on the quality of life (QoL) among patients with CD. A new PROM scale has been developed to measure CD anorectal stricture.
Methods:
A 3-phase mixed-methods approach was implemented. Items were generated through a literature review and semi-structured interviews, followed by screening and refinement via pre-surveys and the Delphi method to create an initial scale. Cognitive interviews with patients were conducted to further optimize item content. Psychometric validation included structural validity assessments (comparisons with the hospital anxiety and depression scale [HADS] and the inflammatory bowel disease questionnaire [IBDQ]), as well as reliability and sensitivity evaluations through test-retest analysis.
Results:
The study involved 171 patients with CD-associated anorectal stricture, 13 colorectal surgeons, 3 gastroenterologists, 1 general surgeon, and 1 nurse (all specializing in CD), along with 2 researchers experienced in PROM design, leading to the development of the Crohn's disease Anorectal Stricture Quality of Life Scale (CDAS-QoL). The scale demonstrated high internal consistency and reliability (Cronbach's α = 0.92; Guttman split-half = 0.84), good stability (Intraclass correlation coefficient = 0.87), and sensitivity (lower scores in patients with symptom improvement, P = .001; higher scores in those with symptom worsening, P = .03). CDAS-QoL scores were positively correlated with HADS scores (r = 0.66, P < .001) and negatively correlated with IBDQ scores (r = -0.67, P < .001).
Conclusions:
The CDAS-QoL scale is a validated PROM tool applicable to clinical decision-making and trials. It provides an effective instrument to quantify the severity of anorectal stricture in CD and assess its impact on patients' QoL.
More Related Videos
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
Related Concept Videos
01:25Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
01:17Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are: